Flatirons Family Is Not Your Traditional Pharmacy
The Colorado business is expanding, offering animal and human compounding, as well as flu, hormone, pharmacogenomics, and strep testing.
Caplyta From Intra-Cellular Therapies, Inc
Caplyta is an atypical antipsychotic and is thought to exert its effect through a combination of antagonist activity at central serotonin 5-HT2A receptors and postsynaptic antagonist activity at central dopamine D2 receptors.
Women With Autoimmune Thyroid Disease Have Higher Risk of PCOS
Autoimmune diseases in general affect women more frequently than men, and thyroid disease, in particular, is very common.
New Regulations Aim to Reform Self-Referral Stark Law
When the Stark Law, or ethics in patient referrals act, was passed in 1989, its purpose was to prevent physicians from referring patients to designated health service entities in which they had financial interest.
Middle-Aged Women Often Develop Hypertension
They may respond better to some antihypertensives than men, although they typically experience more and worse adverse effects.
OTC Case Studies: Women's Health
Four OTC cases are presented for women's health.
Toxicity Is a Risk of PAMORA Interactions
Peripherally acting M-opioid receptor antagonists can improve quality of life but differ variably by impact from concomitant medications.
Pharmacy's History: Jonas Salk’s Virus Research Led to the Polio Vaccine
The medical pioneer never patented or profited from his work that saved untold numbers of lives.
Pharmacy Schools Are Important for MTM Services
They Can Prepare Students for Medication Therapy Management Practice Settings Through the Curriculum and Clinical Rotations
Hypothyroidism Is Associated With Lower Risk in Breast Cancer
One in 8 women will develop breast cancer within their lifetime, making it the most commonly diagnosed cancer among women.
Prescription Validation Is a Critical Task
Pharmacists count on techs’ help to complement their knowledge and ease their burden
Case Studies (June 2020)
Interactive case studies from the June 2020 issue.
Pet Peeves (June 2020)
What's bothering you?
Supplements Can Help Maintain Ideal Levels of Neurochemicals
Nutrients should come from food, but when that is not enough, vitamin supplementation is an option
Pharmacy Chain Terminates Technician for Tardiness
A pharmacy technician in a Midwestern state filed a lawsuit against his former employer alleging his termination violated the law.
FDA Approves First Nonhormonal Prescription Gel to Prevent Pregnancy
New contraceptive from Evofem Biosciences maintains acidic environment inhospitable to sperm.
Operational Changes Related to Pandemic Can Open Up Risks
Pharmacies must take steps to safeguard prescription delivery and verbal communication during the COVID-19 crisis.
Important Education for Patients Regarding a Long-Lasting Reversible Contraceptive
Hormone Replacement Therapy Most Benefits Women Under 60
Pharmacists can play an important role in counseling patients about the benefits and risks based on age and medical history.
FDA Approves New Treatment for Thyroid Eye Disease
Teprotumumabtrbw is the first drug to be approved for the treatment of TED.
Generic Product News (June 2020)
Pharmacy Times reveals June 2020's recommended generic products.
Rx Product News (June 2020)
RX products featured in the June 2020 issue.
OTC Product News (June 2020)
OTC products featured in the June 2020 issue.
Pharmacists Address Proper Dosing of Anticoagulants in CAD and PAD
In a Pharmacy Times® Insights series, 2 experts agree that communication is incredibly valuable when discussing guidelines and recommendations.
Let’s Be Ready to Test and Vaccinate
No matter how it all shakes out, pharmacists now have a level of responsibility they never had before.
Stay Up to Date on New COVID-19 Data in Specific Populations
As the overall data on this illness continue to emerge, it will be important for health care providers to watch its impact on different populations and to serve as a source of reliable information for them.
FDA Issues Guidance for Developers of Chloroquine and Hydroxychloroquine
In response to high demand for the unproven COVID-19 treatments, chloroquine and hydroxychloroquine, the FDA has issued 2 product-specific guidance documents for manufacturers.
2 Clarke Drive Cranbury, NJ 08512